Latest It Distribution News

Orthocell has rapidly expanded its US distributor network for Remplir™, surpassing its target ahead of schedule and positioning itself for imminent sales in the $1.6 billion nerve repair market.

Macquarie Group Limited has announced an ordinary dividend of AUD 1.4663 per security for its perpetual capital notes, payable in June 2025 with partial franking.

Macquarie Group Limited has announced a quarterly ordinary dividend of AUD 1.7124 per security on its perpetual capital notes, with a 35% franking rate and a total distribution yield of 6.79% per annum.

GQG Partners reported a steady increase in funds under management to US$163.6 billion as of April 30, 2025, driven by strong inflows in International and U.S. Equity strategies.

AVITA Medical reported a strong first quarter with revenues up 67% to $18.5 million, driven by expanded commercial sales and new product introductions. Despite a narrower net loss, the company faces ongoing challenges from revenue covenants and macroeconomic pressures.

Macquarie Bank Limited reported an 18% rise in net profit for FY2025, driven by growth in its retail banking segment despite margin pressures, while its commodities business faced subdued markets. The bank maintained strong capital ratios and advanced its risk and technology frameworks amid regulatory scrutiny.

Macquarie Group Limited has announced a fully franked ordinary dividend of AUD 3.90 per share for the half-year ending March 2025, accompanied by a dividend reinvestment plan with no discount.

Judo Capital Holdings clarifies its recent Q3 financial disclosures, affirming compliance with ASX rules while highlighting FY26 profit guidance as material information.

Washington H Soul Pattinson & Company Limited has confirmed a fully franked ordinary dividend of AUD 0.44 per share for the half-year ending January 2025, alongside an updated Dividend Reinvestment Plan price of AUD 37.02.

Generation Development Group (GDG) has forged a strategic alliance with BlackRock, combining local market leadership with global investment expertise to develop innovative retirement income solutions for Australian retirees.

NTAW Holdings has terminated its Australian Dunlop tyre distribution agreements, entering new contracts with Sumitomo Rubber Industries and Goodyear entities, while continuing Dunlop distribution in New Zealand. The move marks a strategic pivot as NTAW aims to grow other business units and reduce costs.

Neuren Pharmaceuticals reports a robust 11% rise in DAYBUE™ US net sales for Q1 2025, alongside a 17% jump in royalty income, setting the stage for an anticipated European market entry in early 2026.